Infections in recipients of liver homografts.

PubWeight™: 1.92‹?› | Rank: Top 3%

🔗 View Article (PMC 2772060)

Published in N Engl J Med on September 19, 1968

Authors

V A Fulginiti, R Scribner, C G Groth, C W Putnam, L Brettschneider, S Gilbert, K A Porter, T E Starzl

Articles citing this

Evolution of liver transplantation. Hepatology (1982) 19.54

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Fungus infections after liver transplantation. Ann Surg (1977) 1.81

Liver transplantation in man. II. A report of two orthotopic liver transplants in adult recipients. Br Med J (1968) 1.68

Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50

Effect of chemotherapeutic agents upon microorganisms isolated from cancer patients. Antimicrob Agents Chemother (1972) 1.29

OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11

Suppression of reticuloendothelial function in the rat with cyclophosphamide. J Bacteriol (1969) 1.10

Liver transplantation: where it's been and where it's going. Gastroenterol Clin North Am (1988) 1.01

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I). J Transl Med (2011) 0.97

Infectious complications in bone marrow transplant patients. Br Med J (1971) 0.93

Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery (1991) 0.91

Neuropathologic findings after liver transplantation. Acta Neuropathol (1992) 0.90

Human immune responses to major human cytomegalovirus glycoprotein complexes. J Virol (1988) 0.88

Systemic candidiasis, a diagnostic challenge. Calif Med (1972) 0.86

Successful treatment of tuberculosis in renal transplant recipients. J R Soc Med (1978) 0.83

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation. Trials (2012) 0.83

Prevalence of cytomegalovirus infection in a normal urban population in Nova Scotia. Can Med Assoc J (1969) 0.76

Problems with immunosuppressive agents in renal disease. J Clin Pathol Suppl (R Coll Pathol) (1975) 0.75

Infectious diseases. Annual review of significant publications. Postgrad Med J (1969) 0.75

Articles cited by this

HOMOTRANSPLANTATION OF THE LIVER IN HUMANS. Surg Gynecol Obstet (1963) 10.22

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99

Specific bacteriologic problems after orthotopic liver transplantation in dogs and pigs. Arch Surg (1968) 2.32

THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet (1968) 2.20

Pneumocystis carinii pneumonia. Studies on the diagnosis and treatment. Ann Intern Med (1966) 2.17

INFECTIOUS DISEASES ASSOCIATED WITH RENAL HOMOTRANSPLANTATION. JAMA (1964) 2.14

Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66

A study of antibiotic prophylaxis in unconscious patients. N Engl J Med (1957) 1.51

Changing trends in the casuistics of hepatic abscess. Am J Med (1960) 1.50

Prophylactic antimicrobial drugs in surgery. N Engl J Med (1966) 1.33

Some urological aspects of 93 consecutive renal homotransplants in modified recipients. J Urol (1967) 1.32

SUCCESSFUL TREATMENT OF PNEUMOCYSTIS CARINII PNEUMONITIS IN A PATIENT WITH CONGENITAL HYPOGAMMAGLOBULINEMIA. N Engl J Med (1965) 1.27

Thymic alymphoplasia. Arch Dis Child (1967) 1.27

Thymic dysplasia. A separable entity from "swiss agammaglobulinemia". Am J Med Sci (1967) 1.11

Cytomegalovirus syndrome in children with acute leukemia. Treatment with floxuridine. JAMA (1967) 1.10

An assessment of prophylactic antibiotics in general surgery. Surg Gynecol Obstet (1963) 0.94

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

"Broken windows" and the risk of gonorrhea. Am J Public Health (2000) 7.12

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am J Epidemiol (1969) 4.97

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA (1967) 4.01

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A (1999) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26